Type 3 deiodinase (D3), the physiologic inactivator of thyroid hormones, is induced during tissue injury and regeneration. This has led to the hypotheses that D3 impacts injury tolerance by reducing local T3 signaling and contributes to the fall in serum triiodothyronine (T3) observed in up to 75% of sick patients (termed the low T3 syndrome). Here we show that a novel mutant mouse with hepatocyte-specific D3 deficiency has normal local responses to toxin-induced hepatonecrosis, including normal degrees of tissue necrosis and intact regeneration, but accelerated systemic recovery from illness-induced hypothyroxinemia and hypotriiodothyroninemia, demonstrating that peripheral D3 expression is a key modulator of the low T3 syndrome. (Endocrinology 155: 4061-4068, 2014) T ype 3 deiodinase (D3) is the physiologic inactivator of thyroid hormones and is highly expressed in the uteroplacental unit and in fetal tissues where it limits the transfer of maternal thyroid hormone to the embryo (1). The developmental importance of this function is evidenced by the global D3 knockout mouse that suffers from systemic thyroid dysfunction, microsomia, and spontaneous perinatal mortality (2). Although D3 expression falls rapidly after birth, studies over the past decade have documented the robust postnatal reactivation of D3 in diverse injuries that include shock (3), heart failure (4), myocardial infarction (5), stroke (6), pneumonia (7), nerve injury (8), and tumorigenesis (9, 10). More recently, D3 expression has been linked to tissue regeneration in rodent studies (11) (12) (13) showing that liver D3 mRNA and activity increase in parallel with hepatocyte proliferation. These data have formed the basis for the hypothesis that the reactivation of D3 during illness improves injury tolerance and healing by reducing local serum triiodothyronine (T3) availability in the tissue microenvironment (12). Abbreviations: CCl 4 , carbon tetrachloride; D3, type 3 deiodinase; FT3I, free T3 index; FT4I, free T4 index; PCNA, proliferating cell nuclear antigen; SECIS, selenocysteine insertion sequence; T3, serum triiodothyronine.
Type 3 deiodinase (D3), the physiologic inactivator of thyroid hormones, is induced during tissue injury and regeneration. This has led to the hypotheses that D3 impacts injury tolerance by reducing local T3 signaling and contributes to the fall in serum triiodothyronine (T3) observed in up to 75% of sick patients (termed the low T3 syndrome). Here we show that a novel mutant mouse with hepatocyte-specific D3 deficiency has normal local responses to toxin-induced hepatonecrosis, including normal degrees of tissue necrosis and intact regeneration, but accelerated systemic recovery from illness-induced hypothyroxinemia and hypotriiodothyroninemia, demonstrating that peripheral D3 expression is a key modulator of the low T3 syndrome. (Endocrinology 155: 4061-4068, 2014) T ype 3 deiodinase (D3) is the physiologic inactivator of thyroid hormones and is highly expressed in the uteroplacental unit and in fetal tissues where it limits the transfer of maternal thyroid hormone to the embryo (1) . The developmental importance of this function is evidenced by the global D3 knockout mouse that suffers from systemic thyroid dysfunction, microsomia, and spontaneous perinatal mortality (2) . Although D3 expression falls rapidly after birth, studies over the past decade have documented the robust postnatal reactivation of D3 in diverse injuries that include shock (3), heart failure (4), myocardial infarction (5), stroke (6) , pneumonia (7), nerve injury (8) , and tumorigenesis (9, 10) . More recently, D3 expression has been linked to tissue regeneration in rodent studies (11) (12) (13) showing that liver D3 mRNA and activity increase in parallel with hepatocyte proliferation. These data have formed the basis for the hypothesis that the reactivation of D3 during illness improves injury tolerance and healing by reducing local serum triiodothyronine (T3) availability in the tissue microenvironment (12) .
In addition to these local effects, it has also been hypothesized that D3 contributes systemically to the fall in T3 observed in up to 75% of sick patients, termed the low T3 syndrome (12) . This is supported by clinical studies that document D3 expression in the liver and skeletal muscle of intensive care unit patients and an inversely proportional relationship between liver D3 activity and the serum T3:rT3 ratio (3).
Unfortunately, efforts to test the role of D3 in the local and systemic responses to injury in vivo have been complicated by the confounders of central hypothyroidism and perinatal illness in the global D3 knockout mouse (2) . To overcome this, we created a conditional knockout animal with targeted deficiency of D3 only in hepatocytes that we termed the LD3KO mouse. Here we show that LD3KO mice have normal growth and thyroid status in the well state, and normal susceptibility and regenerative responses to toxin-induced hepatonecrosis. Strikingly, the duration of illness-induced hypothyroxinemia and hypotriiodothyronemia was significantly reduced in LD3KO mice, indicating that the injury-induced expression of D3 in peripheral tissues is a key modulator of the low T3 syndrome.
Materials and Methods

Animals
LD3KO mice and D3-flox controls were generated as described in the results. Primary hepatocytes were isolated from male or female mice by the methods of Copps et al (14) . All other experiments used males between 8 and 10 weeks of age. Carbon tetrachloride (CCl 4 ; 0.64 mg per g body weight) was injected ip in 200 L of canola oil in the nonfasted state, between the hours of 10:00 AM and 12:00 PM (15, 16) . Animals were killed by cervical dislocation without anesthesia. Tissues were flash frozen in liquid nitrogen for enzyme/RNA analysis or fixed in formalin for histology. For all time points, 5 to 11 mice per genotype were analyzed. Experiments were approved by the International Animal Care and Use Committee of Boston Children's Hospital.
Deiodination assays
D3 activity was assayed by HPLC as previously described (17) 
Serum and tissue t4 and t3 measurements
Serum total T4 and T3 were measured as previously described using a modified Coat-a-Count RIA (Siemens) and T3 charcoal uptake was used to correct for serum binding and express results as free T4 index (FT4I) and free T3 index (FT3I) (18, 19) . Serum TSH was measured with the Milliplex thyroid hormone and TSH panel (EMD Millipore) (20) . Thyroid hormone was extracted from tissue homogenates with methanol and T4 and T3 levels were measured by liquid-chromatography tandem mass spectrometry (LC-MS/MS) using a Prelude liquid chromatography system coupled to a TSQ Vantage triple quadropole tandem mass spectrometer (Thermo Scientific). The assay detection limits for quantitation of T3 and T4 were set at 50 pg/mL and 100 pg/mL respectively.
Histology and immunohistochemistry
Necrosis was quantified on H&E sections by a custom-designed ImageJ macro script that imports manually drawn regions of interest of injury tissue, automatically subtracts the vessel region, and calculates the corresponding region size and ratio value. Immunohistochemistry was performed as previously described (1) with 1:2000 polyclonal rabbit anti-D3 antibody (NBP1-05767, Novus Biologicals). Isotype negative controls were performed.
Gene expression analysis
Total RNA was extracted from tissues using Trizol (Ambion) and reverse transcribed using the iScript cDNA synthesis kit (BioRad). Quantification of mRNA was performed by the iQ5 Multicolor Real-Time PCR Detection System (Bio-Rad) with SYBR Green as the detector dye. The housekeeping gene cyclophilin A was used as an internal control. Primers sequences are available upon request.
Statistics
Comparisons between genotypes in Figure 1 were performed by unpaired t test. All other comparisons were performed by 2-way ANOVA (time ϫ genotype). Post hoc contrasts were constructed to address specific a priori hypotheses concerning levels and changes over time within and between genotypes. P values Ͻ.05 were considered significant.
Results
Mice with hepatocyte-specific D3 deficiency have normal baseline thyroid status, growth, and hepatic function
We created a conditional knockout animal with targeted deficiency of D3 only in hepatocytes that we termed the LD3KO mouse. D3 is a selenoprotein that requires both an in-frame mRNA UGA codon within its open reading frame and a cis-acting stem loop sequence in the 3ЈUTR called the selenocysteine insertion sequence (SE-CIS) that recodes in-frame UGA codons to specify the amino acid selenocysteine rather than stop (21) . Mutant mice with loxP sites flanking the Dio3 SECIS were gen- ) livers is explained by the absence of recombination in nonhepatocyte cell types within the liver tissue (such as stromal and endothelial cells). D3 enzyme activity was measured in liver tissue (B), isolated primary hepatocytes (C), and the brain (D). **, P Ͻ .01. D1 enzyme activity was measured in the liver (E) and kidney (F). D2 enzyme activity was measured in brain (G). Serum thyroxine and triiodothyronine are expressed as FT4I (H) and FT3I (I). Baseline serum TSH was measured (J). The relative expression of positively regulated thyroid hormoneresponsive liver genes was measured by quantitative RT-PCR (K-N). LD3KO mice have normal body weight (O), liver weight (P), serum total protein concentrations (Q), and liver histology (R; 20ϫ magnification) compared with D3-flox controls. , where oxygen tension is lowest, with relative sparing around the portal triad components, the portal vein (pv), bile ducts (bd), and hepatic artery (20ϫ magnification). Liver D3 activity (B) and liver D1 activity (C) change over the 48-hours post injection. D, Immunohistochemistry (60ϫ magnification) with an antibody targeting the carboxy-terminus of wild-type D3 (present in the product of the D3 flox allele but absent in the product of the recombined D3 null allele) was performed at 24 hours post CCl 4 showing strong positivity in hepatocytes of D3-flox but not LD3KO mice. Specific immunostaining of liver sinusoidal endothelial cells is present in the LD3KO. Boxed areas are shown at a higher magnification in the insets, illustrating that D3-staining cells follow along the length of the sinusoid, a defining feature of endothelial cells. Image-J software was used to mask necrotic areas (E) and calculate percent necrosis (F). Serum alanine aminotransferase (G) increases after CCl 4 injection.
4064
Castroneves
combinase under the hepatocyte-specific albumin promoter (Alb-Cre mice) (22) to generate LD3KO mice (Alb-Cre ϩ/Ϫ ::Dio3 flox/flox ) and D3-flox littermates (Alb-Cre Ϫ/Ϫ ::Dio3 flox/flox ) to serve as negative controls. In the presence of the Alb-Cre transgene, LD3KO mice have hepatocyte-specific excision of the floxed Dio3 SECIS, resulting in a null allele with termination at the UGA codon and no catalytic activity ( Figure 1A) .
As expected, LD3KO mice displayed nearly complete loss of D3 activity in the liver ( Figure 1B) . Assay of isolated primary hepatocytes confirmed that this activity is in hepatocytes and that the efficiency of Cre-lox mediated knockdown is high ( Figure 1C ). This D3 deficiency was tissue-specific, because D3 activity in the brain was unchanged ( Figure 1D ). Contrasting the global D3 knockout mouse (2), the LD3KO showed no compensatory changes in the expression of the thyroid hormone-activating enzymes, types 1(D1) and 2(D2) deiodinase (Figure 1, E-G) .
In contrast to the central hypothyroidism associated with global D3 deficiency (23), baseline serum thyroxine and triiodothyronine concentrations (expressed as FT4I and FT3I, respectively) in the LD3KO were the same as in D3-flox controls (Figure 1, H and I ) and serum TSH was not suppressed (Figure 1J ). Despite the loss of hepatocyte D3, there were no differences in the expression of thyroid hormone-responsive hepatic genes (18) between genotypes ( Figure 1, K-N) . Body weight (Figure 1O ), liver weight ( Figure 1P ), total serum protein ( Figure 1Q ), and liver histology reviewed by a rodent pathologist blinded to the genotype ( Figure 1R ) were the same in LD3KO and D3-flox mice, indicating normal growth, liver development, and hepatic protein synthesis.
LD3KO mice have normal injury tolerance and tissue regeneration after toxinmediated hepatonecrosis
To determine whether hepatocyte D3 deficiency alters the local or systemic responses to injury, we used a classic model of toxin-mediated hepatonecrosis where a single injection of CCl 4 induces acute necrosis surrounding the central veins ( Figure  2A ). CCl 4 was administered in the nonfasted state and animals were allowed free access to normal chow. Body weight was equal between genotypes at the time of dosing ( Figure  1, 0) , as was the nadir of body weight at 24 hours (mean loss of 1.6 Ϯ 0.3 g in D3-flox vs 1.7 Ϯ 0.4 g in LD3KO, P ϭ .80).
In D3-flox mice, this injury was associated with a rise in liver D3 (Figure 2B ) and a decrease in liver D1 ( Figure 2C ). D3 activity was elevated above zero at all times, with P ϭ .001 at 0 hours, P Ͻ .0001 at 24 and 48 hours. In comparison, LD3KO mice showed no liver D3 activity at baseline, but an attenuated burst of D3 expression that peaked prematurely at 24 hours and disappeared by 48 hours. This LD3KO hepatic D3 activity was elevated only at 24 hours (P ϭ .03), but negligible at baseline 0 hours and at 48 hours (P ϭ .74 and 0.63, respectively). The D3 activity observed in LD3KO livers 24 hours post CCl 4 localized to liver sinusoidal endothelial cells (rather than hepatocytes) by immunohistochemistry ( Figure 2D ). Despite lower hepatic D3 expression, the severity of tissue injury was unaffected as the degree of necrosis (Figure 2 , E and F) and the elevation of serum alanine aminotransferase (a standard index of liver injury; Figure 2G ) were equal in LD3KO mice compared with D3-flox controls. To determine if the absence of D3 impairs hepatocyte regeneration, we measured mitotic count ( Figure 3A ) and saw that hepatocyte proliferation was as robust in LD3KO mice as in D3-flox controls and peaked at 48 hours post injection, when liver D3 is maximal in D3-flox mice but negligible in the LD3KO mutant ( Figure 2B ). Further indicating intact regeneration, the expression of proliferating cell markers, including proliferating cell nuclear antigen (PCNA; Figure 3B ) and G 1 cyclins that drive hepatocytes from G 1 into S phase (cyclins A 2 and E 1 ; Figure 3, C and D) (24) , was higher in LD3KO mice compared with D3-flox controls at 48 hours post injection (P Ͻ .005 for all markers). As final confirmation that hepatocytedeficient LD3KO mice are capable of complete regeneration, liver histology from 120 hours post CCl 4 was reviewed by a rodent pathologist blinded to treatment history and was deemed indistinguishable from preinjury (0 hour) specimens ( Figure 3E ).
LD3KO mice display accelerated recovery from the low T3 syndrome
Because these experiments documented normal thyroid status in the well state and normal local responses to liver injury, we next explored the systemic thyroid response to illness. Comparison of serum thyroid function tests in LD3KO versus D3-flox mice revealed an acute fall in serum thyroid hormone at 24 hours post CCl4 that was equal between genotypes, averaging 47% for FT4I (Figure 4A ) and 29% FT3I ( Figure 4B ). Consistent with the expected pattern of the low T3 syndrome, serum FT4I and FT3 remained suppressed between 24 and 48 hours in D3-flox controls. In contrast, LD3KO animals displayed accelerated recovery of systemic thyroid status, characterized by an 81% increase in FT4I (P ϭ .003) and a 76% increase in FT3I (P ϭ .02) between 24 and 48 hours that restored serum concentrations to near preinjury levels. Whereas absolute FT4I and FT3I levels were not significantly different between genotypes at 48 hours (P ϭ .077 or 0.099, respectively), comparisons between 0 and 48 hours confirm that FT4I had returned to pretreatment levels in LD3KO (P ϭ .3126) but not in D3-flox mice (0.0016). An analysis of tissue T4 and T3 in the livers of these animals showed no significant difference between genotypes by 2-way ANOVA (genotype ϫ time), but did display a pattern paralleling the serum changes, with higher tissue T4 and T3 concentrations in the LD3KO at 48 hours ( Figure 4, C and D) .
Discussion
The observation that D3 is induced in diverse tissues during injury has led to the hypotheses that local thyroid hormone inactivation promotes injury tolerance and healing and that D3 also contributes systemically to the low T3 syndrome (12) . Because efforts to test this hypothesis in Figure 4 . LD3KO mice display accelerated recovery from the low T3 syndrome. Serum FT4I (A) and FT3I (B) change over the 48 hours post CCl 4 injection. **, P Ͻ .01; *P Ͻ .05. From 24 to 48 hours, FT4I and FT3I increased significantly in LD3KO mice (P ϭ .003 and P ϭ .02, respectively) but not in D3-flox controls (P ϭ .88 and P ϭ .85, respectively). Liver tissue T4 (C) and T3 (D) concentrations change in parallel to the fluctuations in serum thyroid hormones.
vivo have been complicated by the confounders of central hypothyroidism and perinatal illness in the global D3 knockout mouse (2), we used a conditional knockout animal with targeted deficiency of D3 only in hepatocytes, the LD3KO mouse. In contrast with the global knockout mouse, LD3KO mice have normal growth and thyroid status in the well state. Furthermore, after CCl4-induced hepatonecrosis, LD3KO animals displayed normal injury susceptibility and were capable of complete liver regeneration. Strikingly, the duration of illness-induced hypothyroxinemia and hypotriiodothyronemia was significantly reduced in LD3KO mice, providing direct evidence that the expression of D3 in injured tissues contributes to the low T3 syndrome as first proposed by Peeters et al (3) .
We have previously shown that D3 inhibits T3-dependent energy expenditure in hepatocytes and neurons and hypothesized that this promotes the viability of injured cells during hypoxic-ischemic stress by reducing their oxygen requirements (4) . Thus, the D3 induction in settings such as liver ischemia (3), myocardial infarction (5), and stroke (6) might limit cell death and injury severity. To test this, we used a classic mouse model of toxin-induced liver necrosis and observed equal amounts of necrosis in LD3KO mice compared with D3-flox controls. Thus, the favorable effects of endogenous D3 on energy expenditure that we previously reported in isolated hepatocytes (4) are either unnecessary for tolerance to this injury or provided indirectly through the paracrine action of other D3-expressing cells. It is also possible that injured hepatocytes are protected from T3 action in vivo by rapid decreases in the T4-activating D1 enzyme and/or by the acute hypothyroxinemia and hypotriiodothyronemia induced by liver necrosis.
Our CCl 4 model also provided the opportunity to directly examine the role of D3 in tissue regeneration. Experiments in isolated cell systems have shown that D3 can function as a potent cell-autonomous (25) (26) (27) or even paracrine (6) regulator of proliferation and differentiation (28) and, as seminal experiments by Kester et al (11) documented the dynamic induction of hepatocyte D3 during liver regeneration, it has been postulated that local inactivation of thyroid hormone by D3 is necessary for the growth of regenerating tissues. Our studies of the LD3KO mouse refute this specific hypothesis by showing that both acute (as measured by mitotic count, PCNA, and cyclin expression) and late (as measured by the complete normalization of liver histology) regeneration are intact in D3-deficient hepatocytes. Although this indicates that hepatocyte D3 is not required for liver regeneration, it should not be misinterpreted as proof that D3 is unimportant for other regenerative processes and, even in this model, it is possible that D3 influences liver regeneration through the sinusoidal endothelial cells (29 -31) or other resident cell types. Because the LD3KO mouse indicates high efficiency of our Cre-lox strategy, the generation of conditional knockout mice with endothelial-specific D3 deficiency may be considered in the future to test this.
It is important to stress that the low T3 syndrome is multifactorial and dependent upon illness severity. In this context, it is remarkable that mice with only hepatocytespecific D3 deficiency displayed significant alterations in systemic thyroid status and that these changes occurred in a disease model where cellular D3 appears unnecessary for local injury tolerance or regeneration. In humans, there is a graded progression of thyroid hormone derangement during illness, characterized by an early fall in serum T3 that occurs with moderate sickness. With more severe or prolonged illness, this is followed by a decrease in serum T4 and TSH as the hypothalamic-pituitary-thyroid axis becomes suppressed. In individuals who recover from critical illness, thyrotroph function returns to produce a rise in serum TSH and the normalization of serum T4 and T3. Rodents that are injured or fasted recapitulate these changes over a foreshortened time course and are thus an ideal animal model of the low T3 syndrome (21, 22) . LD3KO animals showed accelerated recovery from the low T3 syndrome. Based upon the trends of higher baseline serum TSH and higher 48-hour G 1 cyclin expression in LD3KO animals, increased TSH secretion and hepatocyte proliferation may be contributors to this.
Comparison of serum thyroid function tests in LD3KO versus D3-flox mice suggests that factors other than D3 (such as decreased glandular secretion or inhibition of T4 to T3 conversion) are the dominant effectors for the initial injury-induced fall in serum FT4I and FT3I. This resembles the findings of a prior study of bacterial sepsis in the global D3KO mice where D3-deficient animals displayed a fall with both serum T3 and T4 within 48 hours of S. pneumonia infection (32) . In contrast, the accelerated recovery of LDKO mice from CCl 4 -induced hypothyroxinemia and hypotriiodothyronemia indicates that peripheral D3 expression is an important determinant of the duration of the low T3 syndrome. Studies of other mouse injury models are justified to determine if this is generalizable to other types of illness. Given the importance of food intake in thyroid hormone metabolism, pair-fed studies should also be considered.
In summary, our data illustrate that D3 is not an absolute requirement for regeneration in all tissues but do indicate a novel role of peripheral D3 expression in the low T3 syndrome. From a broad perspective, our results also validate the use of conditional knockout approaches to dissect the in vivo functions of D3 and the impact of thyroid hormone signaling during critical illness. More experiments are warranted to explore the downstream effects of injury-induced D3. However, the present study offers a new paradigm to understand recovery from the low T3 syndrome and may support that increased local T3 signaling could enhance the reversal of systemic illness in some disease settings.
